| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |